Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / GENOMIC REV ETF
-
Total 13F shares
-
21,611,541
-
Share change
-
-1,303,127
-
Total reported value
-
$526,299,881
-
Put/Call ratio
-
111%
-
Price per share
-
$24.35
-
Number of holders
-
208
-
Value change
-
-$30,340,417
-
Number of buys
-
71
-
Number of sells
-
98
Institutional Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q2 2025
As of 30 Jun 2025,
ARK ETF TR - GENOMIC REV ETF (ARKG) was held by
208 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,611,541 shares.
The largest 10 holders included
JPMORGAN CHASE & CO, GOLDMAN SACHS GROUP INC, BNP PARIBAS FINANCIAL MARKETS, MORGAN STANLEY, UBS Group AG, WELLS FARGO & COMPANY/MN, STATE OF WISCONSIN INVESTMENT BOARD, LPL Financial LLC, CITIGROUP INC, and BANK OF AMERICA CORP /DE/.
This page lists
210
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.